Diabetes · Tallahassee, FL
Diabetes studies in Tallahassee, FL
2 recruiting studies have a site in Tallahassee.
2 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
Eli Lilly and Company
- Location
- Tallahassee, FL + 3 other US sites
- Eligibility basics
- Ages 1–35
- RecruitingPhase 3
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Eli Lilly and Company
- Location
- Tallahassee, FL + 3 other US sites
- Eligibility basics
- Ages 1–35
Who these studies look for
Studies commonly set an HbA1c range, a diagnosis duration and a list of allowed or excluded medications. Some also recruit people without diabetes as a comparison group.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.